CDH1 and cancer: In the knockout study, E-cadherin loss decreased CTCs in the bloodstream and suppressed metastasis due to reduced cell proliferation and increased apoptosis (Padmanaban et al., 2019), while increased E-cadherin engagement in the second study resulted in suppression of cancer metastasis (Na et al., 2020).